相关实验视频
Updated: Jun 12, 2025

07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
84.8K
探索HIF1A在肺腺癌的预后和治疗价值
Zhimin Lu1, Yanyu Bi2, Jialu Jiang2
1Department of Outpatient, Affiliated Hospital of Jiaxing University, The First Hospital of Jiaxing, Jiaxing, Zhejiang, China.
Heliyon
|September 25, 2024
概括
缺氧诱导的1A因子 (HIF1A) 在肺癌中受到上调,并且与肺腺癌 (LUAD) 的不良结果有关. 针对HIF1A可能为LUAD患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 肺腺癌 (LUAD) 和肺平细胞癌 (LUSC) 是非小细胞肺癌 (NSCLC) 的主要类型.
- 缺氧诱导的1A因子 (HIF1A) 是细胞对缺氧反应的关键调节者.
- 了解HIF1A在NSCLC中的作用对于开发向疗法至关重要.
研究的目的:
- 调查HIF1A表达和LUAD和LUSC的临床特征之间的相关性.
- 评估HIF1A在NSCLC亚型中的预后意义.
- 探索针对LUAD中HIF1A的潜在治疗策略.
主要方法:
- 在瘤组织中对HIF1AmRNA表达的生物信息分析.
- 进行元分析和生存分析以评估预后价值.
- 在HIF1A相互作用和药物向的in silico预测.
主要成果:
- 与正常肺组织相比,HIF1AmRNA在LUAD和LUSC中都受到上调.
- 升高的HIF1A表达与LUAD的预后不佳有关,但不是LUSC.
- HIF1A影响白细胞透,并表现出免疫抑制作用.
结论:
- HIF1A是LUAD的潜在预后生物标志物.
- HIF1A在瘤微环境和免疫逃避中发挥作用.
- 准HIF1A为LUAD提供了一个有前途的治疗途径.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K

